RudaCure Inc. visited KIC Washington on April 2nd to hold an advisory meeting on U.S. subsidiary establishment, overseas licensing consulting, and overseas market expansion strategies.
This visit was part of the ongoing Bio iCORE project, aimed at establishing a U.S. presence through MassChallenge, expanding business operations, and building a network for the successful execution of RCI001 FDA clinical trials. CEO Yongho Kim, Clinical Team Leader Yuseung Ha, and BD representative Harris Hasrol attended from RudaCure, while Center Director Jeonghwan Moon, Division Head Yongbeom Kim, and Team Leader Wooseop Lee participated from KIC, expressing strong commitment to actively supporting RudaCure's U.S. market entry and overseas investment attraction.
KOTRA U.S. Business Center
KIC Washington